TerrAscend remains focused on the execution of its U.S. expansion strategy. To date, the Company has grown its U.S. presence, both organically and through targeted strategic acquisitions, which include Arise Bioscience, The Apothecarium, Ilera Healthcare, and State Flower. This has enabled TerrAscend to enter new markets and establish a strong foothold. The Company’s U.S expansion strategy is rooted in a commitment to achieving scale and profitability in the select markets where it operates.
A medical marijuana growing and processing facility yet to be built on Route 94 has grown by approximately 30,000 square feet.
The Township Land Use Board, at its virtual meeting Thursday, unanimously approved the expansion for room to install HVAC equipment inside the building and to provide adequate space for mechanical equipment in utility rooms. The changes increase the size of the building across two stories from 381,548 square feet to 411,176 square feet.
New Jersey: Completed construction on more than 50,000ft2 vertically integrated facility with first harvest expected in early July. Actively hiring staff and anticipate opening first dispensary in Vineland in June to take advantage of wholesale supply availability.
The New Jersey Department of Health last week issued a permit to Justice Grown in Ewing to begin growing medical marijuana. The permit was issued after a comprehensive review including several site inspections, background checks of its corporate officers and a review of its security operations and cultivation facility.
The permit will allow the Chicago-based company to serve the more than 74,000 patients in the state from its operation in Ewing Township. Justice Grown broke ground on its indoor cultivation facility on North Olden Avenue in Ewing in late 2019.
The facility will be on the site that formerly housed Verizon, according to Ewing Mayor Bert Steinmann.
Justice Grown is proud to announce that it has officially received a permit to cultivate and process medicinal cannabis products from the New Jersey Department of Health. The permit will allow the company to serve the more than 74,000 patients in the state from its operation in Ewing Township, NJ.
Columbia Care, which holds one of six licenses in New Jersey to cultivate cannabis, has purchased its first location in the Garden State.
The company, a global medical cannabis operation with licenses in 18 jurisdictions in the United States and Europe, bought a vacant industrial building in the southern part of the state at 1560 N. West Blvd. in Vineland for $2.6 million, according to CoStar data.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading vertically integrated cannabis operator in the United States, has been approved as a Clinical Registrant in Pennsylvania by the Commonwealth's Department of Health, Office of Medical Marijuana. Under this designation, the Company will be permitted to open a cultivation and processing facility and up to six dispensaries, under the Commonwealth's medical marijuana research program.
The Company's first medical dispensary in New Jersey is expected to open in Atlantic City in the first quarter of 2020. The 1,300-square-foot facility, located just off the boardwalk on S. New York Avenue, will open as a Be. retail store and will service Atlantic City's estimated 24 million annual visitors. The Company is slated to open a larger Be. flagship facility in the same location pending adult use legalization. The locations of the Company's additional future dispensary sites in New Jersey have yet to be determined.
iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN) (OTCQX: ITHUF), which owns, operates, and partners with best-in-class regulated cannabis operations across the United States, is pleased to announce it has received approval to commence operations at its Pleasantville, NJ cultivation campus. MPX New Jersey, an affiliate of iAnthus, is the ninth Alternative Treatment Center (ATC) in the state to receive a cultivation permit. This marks the tenth state in iAnthus’ operational footprint.